What to expect when you take Omnaris and have Confusion?

Do you take Omnaris and have Confusion? Find out below what new side effects and undetected conditions people who are 50-59 years old may have. This prediction is created after we perform predictive analysis on health care big data. It will be updated regularly.

To personalize this prediction to you, including to your gender, age, personal and family history, and more: Click here



On Aug, 17, 2018

743 reports have been studied.


Females aged 50 to 59 :

570 related reports were analyzed:

Most common symptoms:

Asthma
  • 20.7% for females aged 50 (±5) who take Omnaris
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  • 6.14% for females aged 50 (±5) who take Omnaris
Chest pain
  • 10.88% for females aged 50 (±5) who take Omnaris
Cough
  • 12.98% for females aged 50 (±5) who take Omnaris
Diarrhea
  • 6.14% for females aged 50 (±5) who take Omnaris
Dizziness
  • 13.86% for females aged 50 (±5) who take Omnaris
Dyspnea (difficult or laboured breathing)
  • 21.75% for females aged 50 (±5) who take Omnaris
Fall
  • 8.07% for females aged 50 (±5) who take Omnaris
Fatigue (feeling of tiredness)
  • 18.6% for females aged 50 (±5) who take Omnaris
Headache (pain in head)
  • 18.6% for females aged 50 (±5) who take Omnaris
Heart rate increased
  • 6.32% for females aged 50 (±5) who take Omnaris
High blood pressure
  • 16.14% for females aged 50 (±5) who take Omnaris
Hypersensitivity
  • 5.79% for females aged 50 (±5) who take Omnaris
Hypotension (abnormally low blood pressure)
  • 5.26% for females aged 50 (±5) who take Omnaris
Malaise (a feeling of general discomfort or uneasiness)
  • 11.23% for females aged 50 (±5) who take Omnaris
Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  • 6.14% for females aged 50 (±5) who take Omnaris
Nasopharyngitis (inflammation of the nasopharynx)
  • 12.46% for females aged 50 (±5) who take Omnaris
Nausea (feeling of having an urge to vomit)
  • 8.6% for females aged 50 (±5) who take Omnaris
Oropharyngeal pain
  • 6.32% for females aged 50 (±5) who take Omnaris
Pain
  • 6.32% for females aged 50 (±5) who take Omnaris
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  • 7.02% for females aged 50 (±5) who take Omnaris
Pneumonia
  • 7.19% for females aged 50 (±5) who take Omnaris
Rashes (redness)
  • 5.79% for females aged 50 (±5) who take Omnaris
Sinusitis (inflammation of sinus)
  • 5.26% for females aged 50 (±5) who take Omnaris
Stress and anxiety
  • 8.07% for females aged 50 (±5) who take Omnaris
The flu (the flu is caused by an influenza virus)
  • 8.07% for females aged 50 (±5) who take Omnaris
Weakness
  • 9.65% for females aged 50 (±5) who take Omnaris
Weight decreased
  • 5.09% for females aged 50 (±5) who take Omnaris
Weight increased
  • 5.09% for females aged 50 (±5) who take Omnaris
Wheezing (a high-pitched whistling sound made while you breath)
  • 8.42% for females aged 50 (±5) who take Omnaris

Most common co-existing conditions:

Asthma
  • 47.37% for females aged 50 (±5) who take Omnaris
High blood pressure
  • 8.95% for females aged 50 (±5) who take Omnaris
Hypersensitivity
  • 5.61% for females aged 50 (±5) who take Omnaris
Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
  • 8.42% for females aged 50 (±5) who take Omnaris
Rhinitis perennial (an inflammatory condition of the nose characterized by nasal obstruction, sneezing, itching)
  • 5.61% for females aged 50 (±5) who take Omnaris
back to top

Males aged 50 to 59 :

173 related reports were analyzed:

Most common symptoms:

Arthritis (form of joint disorder that involves inflammation of one or more joints)
  • 6.36% for males aged 50 (±5) who take Omnaris
Asthma
  • 19.08% for males aged 50 (±5) who take Omnaris
Body temperature decreased
  • 7.51% for males aged 50 (±5) who take Omnaris
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  • 5.78% for males aged 50 (±5) who take Omnaris
Chest pain
  • 8.09% for males aged 50 (±5) who take Omnaris
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  • 6.36% for males aged 50 (±5) who take Omnaris
Cough
  • 14.45% for males aged 50 (±5) who take Omnaris
Dizziness
  • 10.4% for males aged 50 (±5) who take Omnaris
Drug ineffective
  • 5.2% for males aged 50 (±5) who take Omnaris
Dyspnea (difficult or laboured breathing)
  • 18.5% for males aged 50 (±5) who take Omnaris
Fatigue (feeling of tiredness)
  • 22.54% for males aged 50 (±5) who take Omnaris
Fever
  • 9.83% for males aged 50 (±5) who take Omnaris
Headache (pain in head)
  • 10.4% for males aged 50 (±5) who take Omnaris
Heart rate increased
  • 10.4% for males aged 50 (±5) who take Omnaris
High blood pressure
  • 14.45% for males aged 50 (±5) who take Omnaris
Hypersensitivity
  • 8.67% for males aged 50 (±5) who take Omnaris
Hypotension (abnormally low blood pressure)
  • 6.94% for males aged 50 (±5) who take Omnaris
Joint pain
  • 5.2% for males aged 50 (±5) who take Omnaris
Lower respiratory tract infection
  • 5.2% for males aged 50 (±5) who take Omnaris
Malaise (a feeling of general discomfort or uneasiness)
  • 19.08% for males aged 50 (±5) who take Omnaris
Muscle aches (muscle pain)
  • 5.78% for males aged 50 (±5) who take Omnaris
Muscle spasms (muscle contraction)
  • 6.94% for males aged 50 (±5) who take Omnaris
Nasopharyngitis (inflammation of the nasopharynx)
  • 21.97% for males aged 50 (±5) who take Omnaris
Nausea (feeling of having an urge to vomit)
  • 8.09% for males aged 50 (±5) who take Omnaris
Oropharyngeal pain
  • 8.09% for males aged 50 (±5) who take Omnaris
Pain
  • 12.14% for males aged 50 (±5) who take Omnaris
Pneumonia
  • 11.56% for males aged 50 (±5) who take Omnaris
Productive cough
  • 10.4% for males aged 50 (±5) who take Omnaris
Rashes (redness)
  • 5.78% for males aged 50 (±5) who take Omnaris
Respiratory disorder (respiratory disease)
  • 5.78% for males aged 50 (±5) who take Omnaris
Sinus congestion (blockage of sinus)
  • 6.94% for males aged 50 (±5) who take Omnaris
Sinusitis (inflammation of sinus)
  • 5.2% for males aged 50 (±5) who take Omnaris
Sputum discolored
  • 6.36% for males aged 50 (±5) who take Omnaris
The flu (the flu is caused by an influenza virus)
  • 14.45% for males aged 50 (±5) who take Omnaris
Weakness
  • 13.29% for males aged 50 (±5) who take Omnaris
Weight increased
  • 6.36% for males aged 50 (±5) who take Omnaris
Wheezing (a high-pitched whistling sound made while you breath)
  • 15.03% for males aged 50 (±5) who take Omnaris

Most common co-existing conditions:

Asthma
  • 54.34% for males aged 50 (±5) who take Omnaris
back to top

Related studies

omnaris

Omnaris has active ingredients of ciclesonide. It is often used in allergies. (latest outcomes from Omnaris 993 users)

confusion

Confusion has been reported by people with depression, high blood pressure, pain, multiple sclerosis, stress and anxiety (latest reports from 46,245 Confusion patients).

Omnaris and Confusion

Analysis tools (to study 499 million drug outcomes from FDA)

  • Check symptoms - identify the cause of a symptom: from a drug or from a condition?
  • Check drugs - find out common side effects or drug interactions of my drugs.
  • Compare drugs - compare the side effects and efficacy of multiple drugs side by side.

You are not alone. Join our personalized support groups:

You may be interested in these posts

More posts for: Omnaris, Confusion

Recent updates

General studies
Active Support Groups
Recent Care Guides

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on ePatient.care is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the ePatient.care site and its content is at your own risk.